Literature DB >> 8360508

Purification of antibodies using protein L-binding framework structures in the light chain variable domain.

B H Nilson1, L Lögdberg, W Kastern, L Björck, B Akerström.   

Abstract

Protein L from the bacterial species Peptostreptococcus magnus binds specifically to the variable domain of Ig light chains, without interfering with the antigen-binding site. In this work a genetically engineered fragment of protein L, including four of the repeated Ig-binding repeat units, was employed for the purification of Ig from various sources. Thus, IgG, IgM, and IgA were purified from human and mouse serum in a single step using protein L-Sepharose affinity chromatography. Moreover, human and mouse monoclonal IgG, IgM, and IgA, and human IgG Fab fragments, as well as a mouse/human chimeric recombinant antibody, could be purified from cultures of hybridoma cells or antibody-producing bacterial cells, with protein L-Sepharose. This was also the case with a humanized mouse antibody, in which mouse hypervariable antigen-binding regions had been introduced into a protein L-binding kappa subtype III human IgG. These experiments demonstrate that it is possible to engineer antibodies and antibody fragments (Fab, Fv) with protein L-binding framework regions, which can then be utilized in a protein L-based purification protocol.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8360508     DOI: 10.1016/0022-1759(93)90273-a

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  17 in total

Review 1.  Recombinant IgA production for mucosal passive immunization, advancing beyond the hurdles.

Authors:  Vikram Virdi; Paloma Juarez; Veronique Boudolf; Ann Depicker
Journal:  Cell Mol Life Sci       Date:  2015-10-28       Impact factor: 9.261

2.  Purification and functional characterization of mucosal IgA from vaccinated and SIV-infected rhesus macaques.

Authors:  Thomas Musich; Thorsten Demberg; Ian L Morgan; Jacob D Estes; Genoveffa Franchini; Marjorie Robert-Guroff
Journal:  Clin Immunol       Date:  2015-04-01       Impact factor: 3.969

3.  Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency.

Authors:  Chen Chen; Tetsuya Wakabayashi; Masaru Muraoka; Feng Shu; Chia Wei Shan; Chong Chor Kun; Ching Tim Jang; Ishin Soehano; Yuichiro Shimizu; Tomoyuki Igawa; Jun-Ichi Nezu
Journal:  MAbs       Date:  2019-03-21       Impact factor: 5.857

4.  Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid.

Authors:  Diana V Pastrana; Katherine A Pumphrey; Nicolas Cuburu; Rachel M Schowalter; Christopher B Buck
Journal:  Virology       Date:  2010-07-03       Impact factor: 3.616

5.  Studies on a single immunoglobulin-binding domain of protein L from Peptostreptococcus magnus: the role of tyrosine-53 in the reaction with human IgG.

Authors:  J A Beckingham; N G Housden; N M Muir; S P Bottomley; M G Gore
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

6.  Use of the amicyanin signal sequence for efficient periplasmic expression in E. coli of a human antibody light chain variable domain.

Authors:  Brian A Dow; Suren A Tatulian; Victor L Davidson
Journal:  Protein Expr Purif       Date:  2015-01-05       Impact factor: 1.650

7.  PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.

Authors:  Xiu Feng Hu; Jie Li; Scott Vandervalk; Zeping Wang; Nancy S Magnuson; Pei Xiang Xing
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

8.  Real-time Recognition of Mycobacterium tuberculosis and Lipoarabinomannan using the Quartz Crystal Microbalance.

Authors:  Leslie A Hiatt; David E Cliffel
Journal:  Sens Actuators B Chem       Date:  2012-08-19       Impact factor: 7.460

9.  Protein L: a novel reagent for the detection of chimeric antigen receptor (CAR) expression by flow cytometry.

Authors:  Zhili Zheng; Nachimuthu Chinnasamy; Richard A Morgan
Journal:  J Transl Med       Date:  2012-02-13       Impact factor: 5.531

10.  Use of magnetic particles in the purification of IgM antibodies against Taenia solium.

Authors:  L Agueda Perez; Yesenia Castillo; Cindy Espinoza; Luz M Toribio; Yesica Santos; Kevin S Martel; Patricia P Wilkins; Javier A Bustos; Hector H García; Yagahira E Castro-Sesquen
Journal:  Rev Peru Med Exp Salud Publica       Date:  2020-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.